Abstral Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Fentanyl citrate

Indications/Uses

Management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain.

Click to view Abstral detailed prescribing information

Dosage/Direction for Use

Initially 100 mcg. If adequate analgesia is not obtained w/in 15-30 min, supplemental dose of 100 mcg may be administered. If adequate analgesia is not obtained w/in 15-30 min of 1st dose, increase dose to next highest tab strength for the next episode of breakthrough pain. Dose strength for supplemental dose may be increased from 100-200 mcg at doses ≥400 mcg. Not >2 doses should be administered for single episode of breakthrough pain during titration phase. Max: 4 doses daily.

Click to view Abstral detailed prescribing information

Overdosage

View Abstral overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food: Place tab under the tongue & allow to dissolve completely in the sublingual cavity, do not chew/suck/swallow. Do not eat or drink anything until tab is completely dissolved. For patients w/ dry mouth, use water to moisten the buccal mucosa before administration.

Contraindications

Hypersensitivity. Patients w/o maintenance opioid therapy (increased risk of resp depression). Severe resp depression or obstructive lung conditions. Treatment of acute pain other than breakthrough pain.

Click to view Abstral detailed prescribing information

Special Precautions

Tolerance & physical &/or psychological dependence may develop. Discontinue use if serotonin syndrome is suspected. Patients w/ COPD or other medical conditions predisposing to resp depression (eg, myasthenia gravis); susceptible to intracranial effects of hypercapnia eg, showing evidence of raised ICP, reduced consciousness, coma or brain tumours; previous or preexisting bradyarrythmias; hypovolaemia & hypotension; mouth wounds or mucositis. Avoid abrupt w/drawal. May affect ability to drive & use machines. Renal or hepatic impairment. Pregnancy. Not to be used during labour, delivery & lactation. Childn & adolescents <18 yr. Elderly.

Click to view Abstral detailed prescribing information

Use In Pregnancy & Lactation

Click to view Abstral detailed prescribing information

Adverse Reactions

Nausea. Dizziness, headache, somnolence; dyspnoea; stomatitis, vomiting, constipation, dry mouth; hyperhidrosis; fatigue.

Click to view Abstral detailed prescribing information

Drug Interactions

Reduced efficacy w/ CYP3A4 inducers. Increased bioavailability w/ macrolide antibiotics (eg, erythromycin), azole antifungal agents (eg, ketoconazole, itraconazole) or certain PIs (eg, ritonavir), grapefruit juice. Increased CNS depressant effects w/ other morphine derivatives (eg, analgesics & antitussives), general anaesth, skeletal muscle relaxants, sedative antidepressants, sedative H₁-antihistamines, barbiturates, anxiolytics (eg, benzodiazepines), hypnotics, antipsychotics, clonidine. Potentiated sedative effects w/ alcohol. Severe & unpredictable potentiation by MAOIs. Partially antagonised analgesic effect & induced w/drawal symptoms w/ partial opioid agonists/antagonists (eg, buprenorphine, nalbuphine, pentazocine). Increased risk of serotonin syndrome w/ serotonergic agent (eg, SSRI, SNRI or MAOI).

Click to view Abstral detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Abstral detailed prescribing information

Storage

View Abstral storage conditions for details to ensure optimal shelf-life.

Description

View Abstral description for details of the chemical structure and excipients (inactive components).

Action

View Abstral mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Analgesics (Opioid)

ATC Classification

N02AB03 - fentanyl ; Belongs to the class of phenylpiperidine derivative opioids. Used to relieve pain.

Regulatory Classification

Presentation/Packing

Form

Abstral SL tab 100 mcg

Packing/Price

10's

Form

Abstral SL tab 200 mcg

Packing/Price

10's

Form

Abstral SL tab 400 mcg

Packing/Price

10's

Abstral

fentanyl

Manufacturer:

A. Menarini

Distributor:

Zuellig Pharma